-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Mereo BioPharma Group, Maintains $5 Price Target

Benzinga·12/22/2025 11:14:28
Listen to the news
Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $5 price target.